Next Sequence

TechBio Founders #14 : Transforming human antibodies into drugs with Wyatt McDonnell, CEO Infinimmune

Episode Notes

Infinimmune’s founding team are tool builders who design from first principles and have broad expertise across immunology, single cell technologies, protein engineering, computational biology, and genome assembly.Transforming human antibodies into drugs.